WELL after doing hours of research - I discovered that HIVC is being covered by some OTC BB groups.
here is the link to one as posted on RB
ragingbull.com
I will also cut and paste a part of it
OK, HIVC might have something that could be proven to be a major medical
breakthrough in history. Now question is that how much the stock should
be valued in the market place. As far as we know, only one public company
is doing something pretty like what HIVC does. It's VAXGEN, INC. (Nasdaq:
VXGN). VXGN is developing preventive vaccines for worldwide use against
HIV. Last year, VXGN has no sales with a loss over $24 million, but its
stock commands a market cap at $252 million. OTCBB stocks are often
valued at half of its peers on the NASADQ. Thus, this alone could give
HIVC a fair market valuation at $4 per share, not to mention HIVC's
vaccines which might be proven to be more effective than VXGN's. Wow!
Don't forget its potential EPS at $1.20 per share as projected by the
company in 2002. Shall we make another target price for the stock on the
basis of this analysis? No, we are not going to give! We stick with our
target price at $4 to $5! We are conservative, this is how our
subscribers could benefit from our style in this risky OTCBB market
filling with hype, bash, naked manipulation and short, not to mention all
kinds of emotion!
- Last March, the stock has been traded as high as $3.25 per share.
Since then, the stock has been substantially declining to the current
level. The stock has been traded extremely active in the past tens days.
A rumor is circulating now about a possible buyout by a major
pharmaceutical company. Also, we are hearing some major developments are
in the works and should be announced shortly. If one of them or both are
are true, the stock could be well over $5 before investors could grab any
shares. |
